Noticias de QGEN_US

Mercado

Noticias del mercado

Últimas noticias sobre QGEN_US — 156 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: QGEN_US ✕ 156 resultados
22/10/2026 QGEN_US — StreetInsider ES ← EN
JPMorgan rebaja la calificación de Qiagen NV (QGEN) a neutral

JPMorgan Downgrades Qiagen NV (QGEN) to Neutral

22/10/2026 QGEN_US — MarketScreener ES ← EN
Qiagen N.V.: Reducido a Neutral por JP Morgan

Qiagen N.V. : Reduced to Neutral by JP Morgan

22/10/2026 QGEN_US — BioSpectrum Asia ES ← EN
EQT adquirirá QIAGEN en un histórico acuerdo de privatización de 10.800 millones de euros

EQT to Acquire QIAGEN in Landmark €10.8 Billion Take-Private Deal

22/10/2026 QGEN_US — Law360 ES ← EN
Siete empresas asesoran a EQT y Qiagen en un acuerdo de privatización de 12.100 millones de dólares

A long list of firms — including Davis Polk & Wardwell LLP, Linklaters LLP and Milbank LLP — are steering Sweden-based EQT Private Equity's $12.1 billion takeover of life sciences testing company Qiagen NV, according to a Wednesday announcement.

22/10/2026 QGEN_US — MarketScreener ES ← EN
Qiagen acuerda la adquisición de 10.800 millones de euros por parte de EQT

Qiagen Agrees to EUR10.8 Billion Takeover by EQT

21/10/2026 QGEN_US — Briefs Finance ES ← EN
EQT adquirirá Qiagen por unos 9.600 millones de euros

EQT-backed Crown NL Bidco to acquire Qiagen for €46.50/share (~€9.6B) with ADIA and CPPIB participation, marking a major European healthcare buyout.

21/10/2026 QGEN_US — The National Law Review ES ← EN
QIAGEN informa los resultados preliminares del tercer trimestre de 2026

VENLO, Netherlands & GERMANTOWN, Md.--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced preliminary third-quarter 2026 financial results. Net sales were $548 million at both reported and constant exchange rates (CER). Adjusted diluted earnings per share (EPS) were $0.65, also $0.65 CER.

21/10/2026 QGEN_US — Reuters ES ← EN
EQT comprará la empresa de pruebas moleculares Qiagen por 10.800 millones de dólares

EQT to buy molecular testing firm Qiagen for $10.8 billion

21/10/2026 QGEN_US — Bloomberg ES ← EN
EQT alcanza un acuerdo de 9.600 millones de euros para la empresa de pruebas moleculares Qiagen

EQT Reaches €9.6 Billion Deal for Molecular Testing Firm Qiagen

21/10/2026 QGEN_US — Business Wire ES ← EN
QIAGEN informa los resultados preliminares del tercer trimestre de 2026

QIAGEN reports preliminary Q3 2026 results

21/10/2026 QGEN_US — Voice of Alexandria ES ← EN
QIAGEN y EQT Private Equity anuncian un acuerdo sobre una oferta pública de adquisición voluntaria recomendada totalmente en efectivo

VENLO, Netherlands & AMSTERDAM--(BUSINESS WIRE)--Oct 21, 2026--

21/10/2026 QGEN_US — Business Wire ES ← EN
QIAGEN y EQT Private Equity anuncian un acuerdo sobre una oferta pública de adquisición voluntaria recomendada totalmente en efectivo

QIAGEN and EQT Private Equity announce agreement on a recommended voluntary all-cash public takeover offer

21/10/2026 QGEN_US — AD HOC NEWS
Qiagen stock: JPMorgan raised target for Qiagen stock to USD 55.00

Second-quarter revenue beat estimates by USD 7.54 million. Qiagen stock costs EUR 42.81 on October 2

21/10/2026 QGEN_US — AD HOC NEWS
EQT enters advanced talks to buy Qiagen: Qiagen stock gains 1.42 percent

Reuters reported an offer above USD 50 per share on October 20, 2026. Qiagen stock costs EUR 43.44 o

21/10/2026 QGEN_US — MarketBeat
Qiagen N.V. (NYSE:QGEN) Stock Has Consensus Target Price of $43.93 According to Brokerages

Shares of Qiagen N.V. (NYSE:QGEN - Get Free Report) have been assigned an average rating of "Hold" from the fourteen research firms that are presently covering the stock, Marketbeat.com reports. Nine investment analysts have rated the stock with a hold rating, four have given a buy rating and one ha

21/10/2026 QGEN_US — AD HOC NEWS
Qiagen stock: EQT bids above USD 50.00, shares rise pre-market

Bloomberg News said KKR also bid for Qiagen on October 20, 2026. At Lang & Schwarz the stock trades

20/10/2026 QGEN_US — MarketBeat
Qiagen (NYSE:QGEN) Sees Unusually-High Trading Volume - Time to Buy?

Qiagen (NYSE:QGEN) Sees Unusually-High Trading Volume - What

Página 1 de 8